Trial intelligence / Profile preview

Anti-HPV biological protein contact film for high-risk HPV

ChiCTR-TRC-12002017Phase 4Completed

Sponsor
First Affiliated Hospital of Shanxi Medical University
Start
Mar 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of anti-HPV biological protein in human papillomavirus infection (2 arms), sponsored by First Affiliated Hospital of Shanxi Medical University. Primary endpoint: HPV negative conversion rate. Started Mar 2012; status: completed.

02

Drugs

anti-HPV biological protein
03

Conditions

human papillomavirus infection

Beyond the preview

Go deeper on ChiCTR-TRC-12002017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call